BIBR 1087 SE
CAS No. 212321-78-3
BIBR 1087 SE ( Desethyl Dabigatran Etexilate )
Catalog No. M23967 CAS No. 212321-78-3
BIBR 1087 SE is a metabolite of dabigatran etexilate.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
2MG | 83 | In Stock |
|
5MG | 135 | In Stock |
|
10MG | 237 | In Stock |
|
25MG | 500 | In Stock |
|
50MG | 718 | In Stock |
|
100MG | 981 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBIBR 1087 SE
-
NoteResearch use only, not for human use.
-
Brief DescriptionBIBR 1087 SE is a metabolite of dabigatran etexilate.
-
DescriptionBIBR 1087 SE is a metabolite of dabigatran etexilate.
-
SynonymsDesethyl Dabigatran Etexilate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number212321-78-3
-
Formula Weight599.7
-
Molecular FormulaC32H37N7O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (166.76 mM)
-
SMILESO=C(N(C1=CC=CC=N1)CCC(O)=O)C2=CC=C(N(C)C(CNC3=CC=C(C(NC(OCCCCCC)=O)=N)C=C3)=N4)C4=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
BC-1382
BC-1382 is a potent ubiquitin E3 ligase HECTD2 inhibitor that specificly disrupts the HECTD2/PIAS1 interaction(IC50 of 5 nM).BC-1382, that targeted HECTD2 and attenuated lipopolysaccharide (LPS)- and Pseudomonas aeruginosa-induced lung inflammation.?
-
[Asp371]-Tyrosinase ...
Tyrosinase (369-377,YMDGTMSQV) is derived from the membrane protein tyrosinase by posttranslational conversion of the sequence YMNGTMSQV. Presentation of YMDGTMSQV in cells expressing full-length tyrosinase is TAP-(transporter associated with antigen processing) and proteosome-dependent.
-
(2R)-1-(tert-butylam...
(2R)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol; but-2-enedioic acid is a chemical compound.